Ovalbumin (277-287)

General Information


DRACP ID  DRACP01004

Peptide Name   Ovalbumin (277-287)

Sequence  RKIKVYLPRMK

Sequence Length  11

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma 10% Killing=572 µg/ml WST-8 assay 24h 1

Hemolytic Activity  Mouse erythrocytes: 10% Hemolysis>1660µg/ml

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01004

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C66H118N20O13S

Absent amino acids  ACDEFGHNQSTW

Common amino acids  K

Mass  161039

Pl  11.77

Basic residues  5

Acidic residues  0

Hydrophobic residues  3

Net charge  5

Boman Index  -3040

Hydrophobicity  -83.64

Aliphatic Index  97.27

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  149

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32715598

Title  Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin

Doi 10.1002/psc.3276

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.